Effective August 1, 2026, there will be updates to the following InterQual criteria subsets:
CP: Molecular Diagnostics
- Spinal Muscular Atrophy (SMA)
- Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Chromosomal Microarray (CMA) for Congenital or Hereditary Disorders